-
Quanome's XDT signs first enterprise AI inference deal worth over $100M; 60-month term, service start ~2 months
XDT Infrastructure I, LLC, an indirect wholly-owned Quanome subsidiary, signed a Master Services Agreement and initial Order to provide dedicated AI inference capacity for an enterprise customer.
-
Quanome signs $100.9M 60-month AI capacity deal with XPERT; orders 32 GPUs from Compal for $18.8M
XDT Infrastructure signed a Token Factory Master Services Agreement with XPERT SOFTWARE SOLUTIONS PTE. LTD. for AI inference capacity; aggregate committed fees ~$100.9M over a 60-month term.
-
Quanome CEO Yang Li provides up to $15 million revolving loan at 6.0% interest
Quanome Technologies entered a revolving loan agreement with CEO/Chairman Yang Li for up to $15.0 million in non-dilutive growth capital.
-
Quanome signs US$18.8 million NVIDIA GPU infrastructure agreement for XDT AI cloud unit
Agreement dated September 16, 2026 covers roughly US$18.8 million of computing infrastructure powered by NVIDIA GPU technology for subsidiary XDT Infrastructure I, LLC.
-
Quanome signs $18.8M NVIDIA GPU infrastructure deal for AI cloud unit XDT
Signed ~US$18.8M purchase agreement on 9/16/26 for NVIDIA GPU-powered infrastructure via subsidiary XDT Infrastructure I, LLC.
-
Quanome Technologies announces director resignation and appointment of Chao Liu
Xiaoou Li resigned as director effective Sept 21, 2026; no disagreement with company.
-
Quanome signs $18.8M GPU server purchase deal with Compal for AI infrastructure
Purchase and Sale Agreement with Compal Electronics for 32 GPU servers, aggregate price ~US$18.8M.
-
Quanome Technologies launches Global Quantum Council and Scientific Advisory Network
Establishes Global Quantum Council with four streams: Quantum Systems, Molecular Discovery, Advanced Nuclear Technologies, Quantum-Safe Cybersecurity.
-
Quanome Technologies (formerly Lakeside Holding) begins trading under QNME, announces quantum technology focus
Name changed to Quanome Technologies, Inc., effective August 5, 2026.
-
Quanome Technologies (formerly Lakeside Holding) changes name and ticker to QNME
Name change from Lakeside Holding Limited to Quanome Technologies, Inc. effective August 3, 2026.
-
Lakeside Holding receives Nasdaq extension to Jan 4, 2027 to meet $1 bid price rule
Received second notice from Nasdaq granting additional 180-day compliance period until January 4, 2027.
-
Lakeside Holding increases authorized common shares from 200M to 2B, authorizes 1B preferred shares
Authorized common stock increased from 200M to 2B shares via Certificate of Amendment filed July 2, 2026.
-
Co-CEO Henry Liu resigns; Yang Li becomes sole CEO of Lakeside Holding
Henry Liu resigned as Co-Chief Executive Officer effective June 2, 2026.
-
Lakeside holders approve 2B share increase, preferred stock, and sale of American Bear Logistics
All six proposals passed with ~82% for, ~18% against; 93.12% of shares voted.
-
Lakeside Holding receives Nasdaq bid-price deficiency notice; 180-day cure period until July 7, 2026
Closing bid price of common stock below $1.00 for 30 consecutive business days ending Jan 6, 2026.
-
Lakeside Holding raises $784k via private placement of 5.6M shares at $0.14/share
Issued 5,600,000 shares of common stock at $0.14 per share for gross proceeds of $784,000.
-
Lakeside raises $5.88M in private placement; appoints Yang Li as joint CEO
Private placement of 8,400,000 shares at $0.70 each for aggregate proceeds of $5.88 million.
-
Lakeside shareholders reject 3 supermajority proposals; approve treasury strategy, share issuance, equity plan
Proposals to increase common shares to 2B, authorize 1B preferred shares, and lower voting thresholds each failed with ~8.88M for but needed 75% of voting power.
-
Lakeside Holding board sees resignation of Yiye Zhou, appointment of Aik Siang Goh
Yiye Zhou resigned from Board effective Sept 30, 2025; no disagreement with company.
-
Lakeside Holding regains Nasdaq minimum bid price compliance
Received deficiency letter July 28, 2025 for bid price below $1.00 for 30 consecutive days.
-
Lakeside Holding appoints new Chairman, COO and independent director; former Chairman/COO resigns
Mr. Lan Su resigned as Chairman of the Board and COO effective Aug 29, 2025; remains subsidiary general manager.
-
Lakeside Holding director Cynthia Vuong resigns effective August 15, 2025
Cynthia Vuong resigned from Board and all committees (Audit, Compensation, Nominating & Governance) effective Aug 15, 2025.
-
Lakeside Holding corrects private placement terms: 2M shares at $0.75 each
Original filing reported 1.5M shares at $1.00; amended to 2.0M shares at $0.75 per share.
-
Lakeside raises $1.5M in private placement of 1.8M shares at $0.83/share
Issued 1,807,229 shares at $0.83 per share for aggregate proceeds of $1.5M.
-
Lakeside Holding receives Nasdaq bid-price deficiency notice; 180 days to cure
Notice received July 28, 2025; closing bid price below $1.00 for 30 consecutive business days since June 12.
-
Lakeside Holding regains Nasdaq minimum shareholders' equity compliance
Nasdaq confirmed on July 24, 2025 that Lakeside meets the $2,500,000 minimum stockholders' equity requirement.
-
Lakeside Holding raises $1.5M in private placement of 1.5M shares at $1.00/share
Issued 1,500,000 shares at $1.00 per share for aggregate proceeds of $1,500,000.
-
Lakeside Holding re-elects all five directors at annual meeting
Annual meeting held June 26, 2025; quorum of 5,768,324 shares (76.9% outstanding).
-
Lakeside raises ~$3M via 3M share issuance to regain Nasdaq equity compliance
Issued 3,000,000 shares of common stock for proceeds of approximately $3 million on June 27, 2025.
-
Lakeside Holding raises $3M via private placement of 3M shares at $1.00 each
Issued 3,000,000 shares at $1.00 per share for gross proceeds of $3,000,000.
-
Lakeside Q3 FY2025 revenue falls 15% to $3.8M; net loss of $1.07M vs prior profit
Total revenue $3.80M, down from $4.46M YoY; cross-border freight fell 26%, pharma distribution added $0.50M.
-
Lakeside Holding closes $500K second tranche of convertible note financing; issues warrants
Second tranche of $500K principal 7% OID secured convertible note closed on April 22, 2025.
-
Lakeside Holding: Chairman Henry Liu resigns from board, remains CEO; two new directors appointed
Henry Liu resigned as chairman and board member effective March 14, 2025; remains CEO of Lakeside Holding.
-
Lakeside (LSH) secures up to $4.5M convertible note financing with 7% OID and warrants
First tranche closed: $1M note and warrants for 318,827 shares at $1.9098, net proceeds $930k.
-
Lakeside Holding receives Nasdaq deficiency notice for insufficient stockholders' equity
Stockholders' equity of $1,646,281 as of Dec 31, 2024 is below Nasdaq's $2.5 million minimum.
-
Lakeside Q2 revenue fell 27% to $3.6M; net loss $1.9M vs prior-year profit
Q2 revenue $3.6M down 26.9% YoY; net loss $1.9M vs net income $0.06M.
-
Lakeside Holding COO Shuai Li resigns; Lan Su appointed effective Dec 9, 2024
Shuai Li resigned as COO effective Dec 9, 2024; no disagreement with company on operations, policies or practices.
-
Lakeside Q1 FY2025 revenue down 1.6%, net loss quadruples to $1.3M
Total revenue $4.08M, down 1.6% YoY; net loss widened to $1.3M from $0.3M.
-
Lakeside subsidiary to acquire 100% of Hupan Pharmaceutical for RMB4M (US$0.6M)
Lakeside's subsidiary Sichuan Hupan signs deal to acquire 100% of Hupan Pharmaceutical for RMB4.0M (US$0.6M).
-
Lakeside Holding FY2024 revenue up 42.3% to $18.3M; net loss of $0.2M vs prior net income
Revenue $18.3M, +42.3% YoY; airfreight surged 117.6% to $10.4M.